ES461100A2 - Procedimiento para preparar compuestos antagonistas de re- ceptores h-2 de histamina. - Google Patents

Procedimiento para preparar compuestos antagonistas de re- ceptores h-2 de histamina.

Info

Publication number
ES461100A2
ES461100A2 ES461100A ES461100A ES461100A2 ES 461100 A2 ES461100 A2 ES 461100A2 ES 461100 A ES461100 A ES 461100A ES 461100 A ES461100 A ES 461100A ES 461100 A2 ES461100 A2 ES 461100A2
Authority
ES
Spain
Prior art keywords
substd
opt
methyl
lower alkyl
imidazolylmethylthio
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES461100A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Smith Kline and French Laboratories Ltd
Original Assignee
Smith Kline and French Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline and French Laboratories Ltd filed Critical Smith Kline and French Laboratories Ltd
Publication of ES461100A2 publication Critical patent/ES461100A2/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/26—Radicals substituted by sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Mejoras introducidas en el objeto de la patente principal nº 434.542 por procedimiento para preparar compuestos antagonistas de receptores H-2 de histamina, de fórmula 1 : **fórmula** en la que X3 y X4 , que pueden ser iguales o diferentes, son cada uno azufre, CHNO2 o NY en donde Y es hidrógeno, hidroxi, alquilo inferior, ciano o CONH, R3 y R4 que pueden ser iguales o diferentes son cada uno una agrupación de fórmula 3: Het-(CH2)mZ(CH2)n en la que Het es un anillo 2- o 4-imidazolilo opcionalmente sustituido por alquilo inferior (preferiblemente metilo), halógeno (preferiblemente cloro o bromo), trifluormetilo o hidroximetilo; un anillo 2- piridilo opcionalmente sustituido por alquilo inferior ( con preferencia metilo), halógeno (con preferencia cloro o bromo), amino, hidroxi o alcoxi inferior (con preferencia metoxi), un anillo 2-tiazolilo; un anillo 3-isotiazolilo opcionalmente sustituido por cloro o amino; Z es azufre o un grupo metileno.
ES461100A 1976-07-28 1977-07-28 Procedimiento para preparar compuestos antagonistas de re- ceptores h-2 de histamina. Expired ES461100A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3139176 1976-07-28

Publications (1)

Publication Number Publication Date
ES461100A2 true ES461100A2 (es) 1978-12-01

Family

ID=10322405

Family Applications (1)

Application Number Title Priority Date Filing Date
ES461100A Expired ES461100A2 (es) 1976-07-28 1977-07-28 Procedimiento para preparar compuestos antagonistas de re- ceptores h-2 de histamina.

Country Status (15)

Country Link
JP (1) JPS5315370A (es)
AU (1) AU2734677A (es)
BE (1) BE857218A (es)
CA (1) CA1070315A (es)
DE (1) DE2733953A1 (es)
DK (1) DK331877A (es)
ES (1) ES461100A2 (es)
FI (1) FI772293A (es)
FR (1) FR2359840A1 (es)
IL (1) IL52544A0 (es)
LU (1) LU77845A1 (es)
NL (1) NL7708375A (es)
NO (1) NO772668L (es)
PL (1) PL107847B1 (es)
ZA (1) ZA774552B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4309435A (en) 1978-10-16 1982-01-05 Imperial Chemical Industries Ltd. Antisecretory guanidine derivatives and pharmaceutical compositions containing them
FR2446829A1 (fr) * 1978-11-16 1980-08-14 Glaxo Group Ltd Derives de polymethylene disubstitues en alpha, omega, procede pour leur preparation et compositions pharmaceutiques les contenant
JPS57102852A (en) * 1980-12-19 1982-06-26 Shionogi & Co Ltd Dicarboxylic acid diamide
EP4196793A1 (en) 2020-08-11 2023-06-21 Université de Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Also Published As

Publication number Publication date
DE2733953A1 (de) 1978-02-02
FR2359840A1 (fr) 1978-02-24
ZA774552B (en) 1978-06-28
DK331877A (da) 1978-01-29
BE857218A (fr) 1978-01-27
IL52544A0 (en) 1977-10-31
AU2734677A (en) 1979-02-01
NL7708375A (nl) 1978-01-31
PL107847B1 (pl) 1980-03-31
FI772293A (es) 1978-01-29
LU77845A1 (es) 1977-10-25
JPS5315370A (en) 1978-02-13
PL199908A1 (pl) 1978-11-20
NO772668L (no) 1978-01-31
CA1070315A (en) 1980-01-22

Similar Documents

Publication Publication Date Title
ES468985A1 (es) Procedimiento para preparar derivados de guanidina
EP0254259A3 (en) P-aminophenol derivatives
FI940680A0 (fi) Menetelmä sulfamoyyli- ja amidinoryhmän sisältävien yhdisteiden valmistamiseksi
ES8704925A1 (es) Un procedimiento para la preparacion de derivados de benzotiazol y benzotiofeno
NO20005881L (no) Heterocykliske forbindelser og metoder for å behandle kardialsvikt og andre sykdommer
HUP0204081A2 (en) 4-pyrimidinyl-n-acyl-l-phenylalanines, pharmaceutical compositions containing them and their use
CA1272482C (en) QUINOLINECARBOXYLIC ACID DERIVATIVES
DK539983D0 (da) Benzoxazolinoner og fremgangsmade til fremstilling deraf
KR910007883A (ko) 퀴놀린 유도체, 그의 제조방법 및 용도
ES461100A2 (es) Procedimiento para preparar compuestos antagonistas de re- ceptores h-2 de histamina.
GB2001624A (en) Guanidine derivatives
ES8603443A1 (es) Procedimiento para la obtencion de derivados piperazinicos
TR21759A (tr) Suebstituee edilmis fenilsuelfoniluere tuerevleri,bunlarin meydana getirilmesine mahsus usul ve herbisid olarak kullanimlari ve bunlarin meydana getirilmesine mahsus yeni ara ueruenler
ES405982A1 (es) Procedimiento para la preparacion de 4-aza-bencimidazoles.
ATE30324T1 (de) Piperazin-derivate von theobromin.
GR78961B (es)
HUP9900914A2 (hu) Simaizom sejtburjánzást gátló sztiril-benzimidazol-származékok
ES8604603A1 (es) Un procedimiento para preparar derivados de 4,5,6,7-tetrahidrotiazolo (4,5-c) piridina
SE8602524L (sv) Kinolinderivat
ES426135A1 (es) Procedimiento de preparacion de esteres de aril-piperazino-alcanoles.
ATE8994T1 (de) Piperazinderivate des theophyllins.
NO794279L (no) Fremgangsmaate til fremstilling av 6,7-dimetoksy-4-amino-2-(4-(furoyl)-1-piperazinyl)-kinazolin-hydroklorid med blodtrykksenkende virkning
IE35505L (en) Heterocyclic thiourea derivatives.
ES421767A2 (es) Un procedimiento para la preparacion de acidos 5-sulfamil- benzoicos sustituidos en la posicion 2.
JO1274B1 (en) Pyridine derivatives